Adlyxin does not contain insulin. It is an injectable prescription drug that may improve blood sugar control in adults with type 2 diabetes when paired with diet and exercise.
Sanofi will offer Adlyxin as a single dose in a disposable pre-filled pen. Patients inject the drug once a day.
Adlyxin has already been approved in more than 60 countries around the world. The Paris-based drugmaker did not say when the treatment would hit the U.S. market.
More articles on the drug market:
FDA approves AbbVie’s drug to treat chronic hepatitis C
Sen. Bernie Sanders’ DNC speech tackles high prescription drug costs: 4 things to know
‘Pain refugees’ travel out of Montana for access to opioid prescriptions
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
